Anesthesiology Doctors in Olean, NY Accepting Medicare

8 Anesthesiology doctors found. Showing 1 - 8

Gabriel E Yacob, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-701-1530    Fax: 716-701-1535

Stephen Douglas Carlson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Sheri Templar, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 202 N Barry St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Douglas B Borromeo, M.D, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Orlando Escuadra Cruz, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Hector Martinez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Wade Rea Porterfield, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 515 Main St, Olean, NY 14760 Phone: 716-372-0223    Fax: 716-373-7191

Hussein Elattar, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 515 Main St., Olean, NY 14760 Phone: 716-323-6570    Fax: 716-323-6658

News Archive

Rutgers Cancer Institute researcher receives grant to explore cell pathway in triple-negative breast cancer

Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $200,000 V Scholar Grant from The V Foundation for Cancer Research to explore a cell pathway in triple-negative breast cancer.

Researchers solve the riddle of superbug toxin damage to gut

A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.

Results from Orion Pharma's ORM-12741 phase IIa study on AD

A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.

Diagnosing Atrial Fibrillation in 30 Seconds

An interview with Glyn Barnes, Marketing Director for AliveCor, about Kardia Mobile and the Kardia Band, the FDA approved devices which can provide a diagnostic quality ECG reading in 30 seconds.

Read more Medical News

› Verified 1 days ago